Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.115
+0.025 (0.61%)
May 27, 2026, 4:00 PM EDT - Market closed

Opus Genetics Revenue

Opus Genetics had revenue of $2.16M in the quarter ending March 31, 2026, a decrease of -50.64%. This brings the company's revenue in the last twelve months to $11.98M, down -12.22% year-over-year. In the year 2025, Opus Genetics had annual revenue of $14.20M with 29.15% growth.

Revenue (ttm)
$11.98M
Revenue Growth
-12.22%
P/S Ratio
23.72
Revenue / Employee
$427,964
Employees
28
Market Cap
293.82M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.20M3.20M29.15%
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 200875.00K--
Dec 31, 200775.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MacroGenics157.08M
Cellectis75.11M
Zentalis Pharmaceuticals26.87M
Surrozen7.49M
Fate Therapeutics6.32M
Armata Pharmaceuticals5.20M
AC Immune4.62M
YD Bio510.36K
Revenue Rankings

IRD News

More News